References
- Anakk S, Huang W, Staudinger JL, Tan K, Cole TJ, Moore DD, Strobel HW. (2007). Gender dictates the nuclear receptor-mediated regulation of CYP3A44. Drug Metab Dispos 35:36–42.
- Anderson BJ, Holford NH. (2009). Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 24:25–36.
- Bühler R, Lindros KO, Nordling A, Johansson I, Ingelman-Sundberg M. (1992). Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur J Biochem 204:407–412.
- Cooper KO, Reik LM, Jayyosi Z, Bandiera S, Kelley M, Ryan DE, Daniel R, McCluskey SA, Levin W, Thomas PE. (1993). Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch Biochem Biophys 301:345–354.
- Hakkola J, Tanaka E, Pelkonen O. (1998). Developmental expression of cytochrome P450 enzymes in human liver. Pharmacol Toxicol 82:209–217.
- Haslam DW, James WP. (2005). Obesity. Lancet 366:1197–1209.
- Johnson TN. (2003). The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192:37–48.
- Johnson TN, Tanner MS, Tucker GT. (2000). A comparison of the ontogeny of enterocytic and hepatic cytochromes P450 3A in the rat. Biochem Pharmacol 60:1601–1610.
- Jump DB, Clarke SD. (1999). Regulation of gene expression by dietary fat. Annu Rev Nutr 19:63–90.
- Kanamori M, Takahashi H, Echizen H. (2002). Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children. Int J Clin Pharmacol Ther 40:485–492.
- Lee CH, Lee MK, Kang CD, Kim YD, Park DY, Kim JY, Sol MY, Suh KS. (2003). Differential expression of hypoxia inducible factor-1 α and tumor cell proliferation between squamous cell carcinomas and adenocarcinomas among operable non-small cell lung carcinomas. J Korean Med Sci 18:196–203.
- Lin JH, Chiba M, Chen IW, Nishime JA, Vastag KJ. (1996). Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence. Drug Metab Dispos 24:1298–1306.
- Mahnke A, Strotkamp D, Roos PH, Hanstein WG, Chabot GG, Nef P. (1997). Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys 337:62–68.
- Michaud J, Leblond FA, Naud J, Boisvert C, Desbiens K, Nicoll-Griffith DA, Pichette V. (2007). Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine. J Pharmacol Toxicol Methods 55:209–213.
- Ni S, Wang X, Wang J, Lu S, Zeng S, Zhao Z, Yu L, Chen S. (2008). Effects of intrauterine undernutrition on the expression of CYP3A23/3A1, PXR, CAR and HNF4α in neonate rats. Biopharm Drug Dispos 29:501–510.
- Ni S, Wang X, Wang J, Zeng S, Zhao Z. (2009). Expression of CYP3A23/1, CYP3A2, PXR, CAR and HNF4α in large-for-gestational-age neonatal rats. Pharmazie 64:252–257.
- Omiecinski CJ, Hassett C, Costa P. (1990). Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1. Mol Pharmacol 38:462–470.
- Pikuleva IA. (2006). Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 112:761–773.
- Salphati L, Benet LZ. (1998). Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochem Pharmacol 55:387–395.
- Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, Zaya MJ. (2003). Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573–582.
- Thummel KE, Wilkinson GR. (1998). In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol 38:389–430.
- Wauthier V, Verbeeck RK, Calderon PB. (2006). Decreased CYP3A2 expression and activity in senescent male Wistar rats: is there a role for HNF4α? Exp Gerontol 41:846–854.
- Wright MC, Edwards RJ, Pimenta M, Ribeiro V, Ratra GS, Lechner MC, Paine AJ. (1997). Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2. Biochem Pharmacol 54:841–846.
- Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. (2004). Maternal nutrition and fetal development. J Nutr 134:2169–2172.
- Yoshinari K, Takagi S, Yoshimasa T, Sugatani J, Miwa M. (2006). Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet. Pharm Res 23:1188–1200.
- Yu AM, Fukamachi K, Krausz KW, Cheung C, Gonzalez FJ. (2005). Potential role for human cytochrome P450 3A4 in estradiol homeostasis. Endocrinology 146:2911–2919.